Compugroup Interest Expense from 2010 to 2026

COP Stock  EUR 26.50  0.02  0.08%   
Compugroup Medical Interest Expense yearly trend continues to be very stable with very little volatility. Interest Expense is likely to grow to about 40.3 M this year. Interest Expense is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. View All Fundamentals
 
Interest Expense  
First Reported
2019-03-31
Previous Quarter
2.7 M
Current Value
8.6 M
Quarterly Volatility
3.4 M
 
Covid
 
Interest Hikes
Check Compugroup Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Compugroup Medical's main balance sheet or income statement drivers, such as Tax Provision of 26 M, Interest Income of 1.2 M or Interest Expense of 40.3 M, as well as many indicators such as . Compugroup financial statements analysis is a perfect complement when working with Compugroup Medical Valuation or Volatility modules.
  
This module can also supplement various Compugroup Medical Technical models . Check out the analysis of Compugroup Medical Correlation against competitors.
Evaluating Compugroup Medical's Interest Expense across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Compugroup Medical SE's fundamental strength.

Latest Compugroup Medical's Interest Expense Growth Pattern

Below is the plot of the Interest Expense of Compugroup Medical SE over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. Compugroup Medical's Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Compugroup Medical's overall financial position and show how it may be relating to other accounts over time.
Interest Expense10 Years Trend
Slightly volatile
   Interest Expense   
       Timeline  

Compugroup Interest Expense Regression Statistics

Arithmetic Mean9,879,230
Geometric Mean0.00
Coefficient Of Variation146.54
Mean Deviation11,391,882
Median4,319,000
Standard Deviation14,476,795
Sample Variance209.6T
Range40.3M
R-Value0.84
Mean Square Error65.9T
R-Squared0.71
Significance0.000025
Slope2,407,824
Total Sum of Squares3353.2T

Compugroup Interest Expense History

202640.3 M
202538.4 M
202433.4 M
202324.3 M
20229.1 M
20215.4 M
20206.4 M

About Compugroup Medical Financial Statements

Compugroup Medical investors utilize fundamental indicators, such as Interest Expense, to predict how Compugroup Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Interest Expense38.4 M40.3 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet

Other Information on Investing in Compugroup Stock

Compugroup Medical financial ratios help investors to determine whether Compugroup Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Compugroup with respect to the benefits of owning Compugroup Medical security.